Strengths and limitations of genetic mouse models of Parkinson's disease
- 1 July 2008
- journal article
- review article
- Published by Elsevier BV in Parkinsonism & Related Disorders
- Vol. 14, S84-S87
- https://doi.org/10.1016/j.parkreldis.2008.04.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptomsExperimental Neurology, 2008
- Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expressionSynapse, 2007
- In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?Experimental Neurology, 2007
- Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synucleinNeuroscience, 2006
- The parkinson's complex: Parkinsonism is just the tip of the icebergAnnals of Neurology, 2006
- Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-SynucleinJournal of Neuroscience, 2004
- Time to move beyond nigrostriatal dopamine deficiency in Parkinson's diseaseAnnals of Neurology, 2004
- Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promotersJournal of Neuroscience Research, 2002
- Basal ganglia and movement disorders: an updateTrends in Neurosciences, 1996
- Basal ganglia and movement disorders: an updateTrends in Neurosciences, 1996